Skip to content

Public FDA record

Z-0779-04: NOW Filariasis Rapid test for W. bancrofti antigen. (Export use only) Item Number 620-430, Kit Number 620

Recall record Z-0779-04 for Binax, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0779-04
Company in FDA record
Binax, Inc.
FDA classification date
Jul 20, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Pouch integrity compromised

Source facts

Action
Binax initiated the recall on 2/18/04 by telephone or email to customers. European customers were notiified by letter.
Initiated
2004-02-18
Root cause
Other
Terminated
2004-08-09
Distribution
KS International: Australia, New Zealand, Japan,Sri-Lanka France, The Netherlands, U.A.E., Oman, S. Africa, Hong Kong, Zimbabwe, India
Recall number
Z-0779-04
Recall status
Terminated
CDRH record ID
31930
FDA classified
2004-07-20
Recall event number
28457

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗